🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Tirzepatide and sulfur burps: GIP receptor-mediated gastric effects — 6 month update Page 3

Tirzepatide and sulfur burps: GIP receptor-mediated gastric effects — 6 month update

JenMemphis Thu, Feb 22, 2024 at 6:05 AM 13 replies 2,050 viewsPage 3 of 3
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Feb 25, 2024 at 3:22 AM#11
Dr.BariatricHTX said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

Agreed on adaptation, with a caveat: adaptation applies to gastric emptying and not to everything. If your problem is the aversion rather than the fullness, waiting does less, because the aversion is central and it is the mechanism working as intended.

Worth separating that from nausea, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

16 14steve_okc, dave_SLC, FDA_TrackerJim and 13 others
Reply Quote Save Share Report
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Feb 27, 2024 at 3:59 PM#12
Dr.PainCLE said:
Agreed on the mechanism, with the caveat that the head-to-head used semaglutide 1mg, not 2.4mg.

Bookmarking. The distinction being drawn above is the one nobody else makes. Taking it to my next appointment.

17 15BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 14 others
Reply Quote Save Share Report
hannah_MT
New Member
23
89
Feb 2026
Bozeman, MT
Mar 1, 2024 at 4:35 AM#13
Dr.BariatricHTX said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

Worth separating that from nausea, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

18 16MaxMetOK, MounjBrad, nick_newbie and 15 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Mar 3, 2024 at 5:10 PM#14

The figures, for anyone assembling their own picture. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

19 17amsterdam_pete, LondonLisa, mike_nyc and 16 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 6, 2024 at 5:43 AM#15

Moderator note: a couple of off-topic posts removed. Report rather than reply if it drifts again.

20 18PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 17 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register